AstraZeneca
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. AstraZeneca's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3% to $45,811,000,000. The net income raised on $5,955,000,000 and profit margin reached 13%. Total operating expenses were $29,578,000,000.
Profit Margin
| 2014 | 26.09B | 1.23B | 4.73% |
|---|---|---|---|
| 2015 | 24.70B | 2.82B | 11.43% |
| 2016 | 23.00B | 3.49B | 15.21% |
| 2017 | 22.46B | 3.00B | 13.36% |
| 2018 | 22.09B | 2.15B | 9.76% |
| 2019 | 24.38B | 1.33B | 5.47% |
| 2020 | 26.61B | 3.19B | 12.01% |
| 2021 | 37.41B | 112M | 0.3% |
| 2022 | 44.35B | 3.28B | 7.41% |
| 2023 | 45.81B | 5.95B | 13% |
AZN.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 45.81B | 44.35B | 37.41B | 26.61B | 24.38B | 22.09B | 22.46B | 23.00B | 24.70B | 26.09B |
Cost of revenue | 8.04B | 12.39B | 12.43B | 5.29B | 4.92B | 4.93B | 4.31B | 4.12B | 4.64B | 5.84B |
Gross profit | 37.77B | 31.96B | 24.98B | 21.31B | 19.46B | 17.15B | 18.14B | 18.87B | 20.06B | 20.25B |
Operating exp. | ||||||||||
Research and development | 10.93B | 9.76B | 9.73B | 5.99B | 5.95B | 5.93B | 5.75B | 5.89B | 5.99B | 5.57B |
Selling and marketing | 18.22B | 18.95B | 15.68B | 11.69B | 11.84B | 10.36B | 10.54B | 9.73B | 11.45B | 13.32B |
Total operating expenses | 29.57B | 28.20B | 23.92B | 16.15B | 16.26B | 13.76B | 14.47B | 13.97B | 15.94B | 18.11B |
Operating income | 8.19B | 3.75B | 1.05B | 5.16B | 2.92B | 3.38B | 3.67B | 4.90B | 4.11B | 2.13B |
Other income (expenses), net | -1.29B | -1.25B | -1.32B | -1.24B | -1.37B | 483M | -1.45B | -20M | -1.04B | -891M |
Income before tax | 6.89B | 2.50B | -265M | 3.91B | 1.54B | 1.99B | 2.22B | 3.55B | 3.06B | 1.24B |
Income tax expense | 938M | -792M | -380M | 772M | 321M | -57M | -641M | 146M | 243M | 11M |
Net income | 5.95B | 3.28B | 112M | 3.19B | 1.33B | 2.15B | 3.00B | 3.49B | 2.82B | 1.23B |
Earnings per share | ||||||||||
Basic EPS | 3.81 | 2.12 | 0.08 | 2.44 | 1.03 | 1.7 | 2.37 | 2.77 | 2.23 | 0.98 |
Diluted EPS | 3.81 | 2.11 | 0.08 | 2.44 | 1.03 | 1.7 | 2.37 | 2.76 | 2.23 | 0.98 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |